特殊情况下机械胸外按压装置的应用
该研究基于德国复苏登记处2007至2020年高质量数据中心院外心脏骤停数据,比较机械胸外按压装置在三种特殊情况下的应用:持续复苏转运、长时间复苏(>45 min)和使用纤溶药物。持续复苏转运患者4851例(装置使用率44.2%),30天生存无差异(OR 1.13,95%CI 0.79-1.60);长时间复苏3920例(装置使用率9.5%),使用装置者30天生存显著改善(OR 2.33,95%CI 1.30-4.15);使用纤溶药物2106例(装置使用率22.2%),使用装置者30天生存显著更差(OR 0.52,95%CI 0.30-0.91)。作者结论:机械装置在转运中未改善生存,但施救者安全仍可能是使用的重要理由;长时间复苏中与更好生存相关,使用纤溶药物时与更差生存相关。
要点
- 持续复苏转运至医院患者4851例(装置使用率44.2%),30天生存无差异(OR 1.13,95%CI 0.79-1.60)。
- 复苏时长>45 min患者3920例(装置使用率9.5%),使用装置者30天生存显著改善(OR 2.33,95%CI 1.30-4.15)。
- 使用纤溶药物患者2106例(装置使用率22.2%),使用装置者30天生存显著更差(OR 0.52,95%CI 0.30-0.91)。
- 使用机械装置的患者更年轻,目击心脏骤停和可除颤初始心律的比例显著更高。
适用人群与场景
- 德国复苏登记处2007至2020年所有高质量数据中心的院外心脏骤停患者。
研究设计与关键结果
- 研究类型:基于德国复苏登记处2007至2020年高质量数据中心院外心脏骤停数据的登记研究;比较机械胸外按压装置在持续复苏转运、长时间复苏(>45 min)和使用纤溶药物三种情况下的应用。
- 持续复苏转运至医院患者4851例(装置使用率44.2%),30天生存无差异(OR 1.13,95%CI 0.79-1.60)。
- 复苏时长>45 min患者3920例(装置使用率9.5%),使用装置者30天生存显著改善(OR 2.33,95%CI 1.30-4.15)。
- 使用纤溶药物患者2106例(装置使用率22.2%),使用装置者30天生存显著更差(OR 0.52,95%CI 0.30-0.91)。
- 使用机械装置的患者更年轻,目击心脏骤停和可除颤初始心律的比例显著更高。
证据类型、等级与局限
- 证据类型:基于德国复苏登记处数据的登记研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:机械装置在持续复苏转运中与更好生存无关,但施救者安全仍可能是使用机械装置的重要理由。
- 作者结论:机械装置在长时间复苏中与更好生存相关,但在使用纤溶药物时与更差生存相关。
指南或共识出处
- 当前复苏指南:在特殊情况下(如持续复苏转运或长时间复苏)可考虑使用机械胸外按压装置。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: According to the current resuscitation guidelines, the use of mechanical chest compression devices could be considered under special circumstances like transport with ongoing resuscitation or long-term resuscitation. The aim of this study was to investigate whether survival is improved using mechanical devices under such circumstances.
METHODS: Out-of-hospital cardiac arrests from all high-quality data centres of the German Resuscitation Registry from 2007 to 2020 were investigated. The use of mechanical devices was compared separately for transport with ongoing resuscitation, prolonged resuscitation (>45 min), and resuscitation with fibrinolytic agents applied. Baseline characteristics, 30-day survival/discharged alive, and neurological function at discharge were analysed descriptively; and 30-day survival/discharged alive was additionally analysed using multivariate logistic regression.
RESULTS: Overall, patients who were treated with a mechanical device tended to be younger and were significantly more likely to have a witnessed cardiac arrest and a shockable initial rhythm. During the study period, 4,851 patients were transported to hospital with ongoing resuscitation (devices used in 44.2%). The 30-day survival was equal (odds ratio, OR: 1.13, 95%-CI: 0.79-1.60). In 3,920 cases, a resuscitation duration > 45 min was documented (9.5% with device). When a device was used, 30-day survival was significantly increased (OR 2.33, 95%-CI: 1.30-4.15). Fibrinolytic agents were used in 2,106 patients (22.2% with device). Here, 30-day survival was significantly worse with a device (OR: 0.52, 95%-CI: 0.30-0.91).
CONCLUSION: Mechanical devices are not associated with better survival when used during transport, but rescuer safety could still be an important argument for their use. Devices are associated with better survival in prolonged resuscitation, but worse survival when a fibrinolytic was used.
参考来源
- Gässler H, Kurka L, Rauch S, et al. Mechanical chest compression devices under special circumstances. Resuscitation. 2022. PMID: 35738309. doi:10.1016/j.resuscitation.2022.06.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。